MTOR and cancer: These interactions activate diverse signaling cascades, including SAPK/JNK (26), PI3K/Akt/mTOR (27), and MAPK/ERK pathways (28), each contributing to distinct aspects of cancer cell survival, immune evasion, stromal activation, and metastatic colonization.